BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis 2020;7:308-19. [PMID: 32884985 DOI: 10.1016/j.gendis.2020.01.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu A, Hu Y, Xu Y, Xu J, Wang X, Cai A, Liu R, Chen L, Wang F. Methyltransferase-Like 3-Mediated m6A Methylation of Hsa_circ_0058493 Accelerates Hepatocellular Carcinoma Progression by Binding to YTH Domain-Containing Protein 1. Front Cell Dev Biol 2021;9:762588. [PMID: 34888309 DOI: 10.3389/fcell.2021.762588] [Reference Citation Analysis]
2 Lee CL, Hong KJ, Kim N, Han K, Kim D, Jung HS, Lee S, Park J, Lee KY, Lee JE, Choi Y, Cho M. Feasibility study of portable multi-energy computed tomography with photon-counting detector for preclinical and clinical applications. Sci Rep 2021;11:22731. [PMID: 34815501 DOI: 10.1038/s41598-021-02210-5] [Reference Citation Analysis]
3 Wang J, Wang Y, Xu J, Song Q, Shangguan J, Xue M, Wang H, Gan J, Gao W. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. Sci Prog 2021;104:368504211029429. [PMID: 34315286 DOI: 10.1177/00368504211029429] [Reference Citation Analysis]
4 Wei W, Xu R, Ying X, Chen L, Lu X, Tang Q, Xie J, Yu H. Transcriptome Analysis of Solute Carrier-Associated Genes in Hepatocellular Carcinoma: Friend or Foe? Front Genet 2022;13:856393. [DOI: 10.3389/fgene.2022.856393] [Reference Citation Analysis]
5 Khairy A, Ibrahim MK, Abdelrahman M, Fouad R, Zayed N, Ayman Y, Abdellatef Z, Yosry A. The diagnostic utility of microRNA 222-3p, microRNA 21-5p, and microRNA 122-5p for HCV-related hepatocellular carcinoma and its relation to direct-acting antiviral therapy. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.04.001] [Reference Citation Analysis]
6 Song W, Zhang X, Feng L, Lai Y, Li T, Zhang P. Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid. CMAR 2022;Volume 14:687-95. [DOI: 10.2147/cmar.s346920] [Reference Citation Analysis]
7 Guan J, Pan Y, Li H, Zhu Y, Gao Y, Wang J, Zhou Y, Guan Z, Yang Z. Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular Carcinoma. Mol Pharm 2022. [PMID: 35508302 DOI: 10.1021/acs.molpharmaceut.2c00026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fang Y, Yang H, Hu G, Lu J, Zhou J, Gao N, Gu Y, Zhang C, Qiu J, Guo Y, Zhang Y, Wen Q, Qiao H. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03282-1] [Reference Citation Analysis]
9 Chen L, Lin YH, Liu GQ, Huang JE, Wei W, Yang ZH, Hu YM, Xie JH, Yu HZ. Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases. Front Genet 2021;12:804916. [PMID: 35096017 DOI: 10.3389/fgene.2021.804916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hernandez-Meza G, Vietti Violi N, Said D, Novogrodsky E, Villavisanis D, Maron SZ, Frere J, Schiano TD, Friedman S, Boffetta P, Branch A, Taouli B. MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center. Abdom Radiol (NY) 2021;46:5142-51. [PMID: 34283266 DOI: 10.1007/s00261-021-03212-7] [Reference Citation Analysis]
11 Zhang CY, Yang M. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis. World J Hepatol 2022; 14(5): 956-971 [DOI: 10.4254/wjh.v14.i5.956] [Reference Citation Analysis]
12 Li YT, Wu HL, Liu CJ. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1. Int J Mol Sci 2021;22:9380. [PMID: 34502289 DOI: 10.3390/ijms22179380] [Reference Citation Analysis]
13 Wang ZZ, Meng T, Yang MY, Wang W, Zhang Y, Liu Y, Han AQ, Wu J, Wang HX, Qian B, Zhu LX. ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma. Transl Oncol 2022;21:101441. [PMID: 35523010 DOI: 10.1016/j.tranon.2022.101441] [Reference Citation Analysis]
14 Huang J, Zhan Y, Jiang L, Gao Y, Zhao B, Zhang Y, Zhang W, Zheng J, Yu J. Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI. Int J Gen Med 2021;14:9555-65. [PMID: 34916837 DOI: 10.2147/IJGM.S338500] [Reference Citation Analysis]
15 Zhang C, Yang M. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis. WJH 2022;14:957-72. [DOI: 10.4254/wjh.v14.i5.957] [Reference Citation Analysis]
16 Ye M, Wang S, Qie JB, Sun PL. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:765484. [PMID: 34671565 DOI: 10.3389/fonc.2021.765484] [Reference Citation Analysis]
17 Zheng W, Feng Y, Bai Y, Feng Z, Yang X, Dang B, Xiao M, Zhang J, Han S. Proanthocyanidins extracted from grape seeds inhibit the growth of hepatocellular carcinoma cells and induce apoptosis through the MAPK/AKT pathway. Food Bioscience 2022;45:101337. [DOI: 10.1016/j.fbio.2021.101337] [Reference Citation Analysis]
18 Shehab-Eldeen S, Metwaly MF, Saber SM, El-Kousy SM, Badr EA, Essa A. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular Carcinoma. Dig Liver Dis 2022:S1590-8658(22)00259-6. [PMID: 35525722 DOI: 10.1016/j.dld.2022.04.015] [Reference Citation Analysis]
19 Zhang S, Jing J, Meng L, Xu B, Ma X, Tian W. Peptide-Conjugated Aggregation-Induced Emission Fluorogenic Probe for Glypican-3 Protein Detection and Hepatocellular Carcinoma Cells Imaging. Chemosensors 2022;10:195. [DOI: 10.3390/chemosensors10050195] [Reference Citation Analysis]
20 Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, Wang K, Wei Q, Wei X, Xu X. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.07.030] [Reference Citation Analysis]
21 Meng J, Wei Y, Deng Q, Li L, Li X. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis. Cancer Cell Int 2022;22:29. [PMID: 35033076 DOI: 10.1186/s12935-021-02439-0] [Reference Citation Analysis]
22 Zeng Z, Lei S, Wang J, Yang Y, Lan J, Tian Q, Chen T, Hao X. A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma. Bioengineered 2022;13:12193-210. [PMID: 35549979 DOI: 10.1080/21655979.2022.2073943] [Reference Citation Analysis]
23 Du F, Sun H, Sun F, Yang S, Tan H, Li X, Chai Y, Jiang Q, Han D. Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs. Front Pharmacol 2022;13:924523. [DOI: 10.3389/fphar.2022.924523] [Reference Citation Analysis]
24 Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16. Front Cell Dev Biol 2021;9:726323. [PMID: 34568335 DOI: 10.3389/fcell.2021.726323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wu K, Travaline CE, Elliot L. Right Atrial Tumor Invasion: A Rare Presentation of Hepatocellular Carcinoma. Cureus. [DOI: 10.7759/cureus.22901] [Reference Citation Analysis]
26 Wang X, Cao L, Wu J, Zhu G, Zhu X, Zhang X, Han D, Shui N, Ni B, Li J. Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology. Evid Based Complement Alternat Med 2021;2021:5773802. [PMID: 34880920 DOI: 10.1155/2021/5773802] [Reference Citation Analysis]
27 Zhao H, Lu B. Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma. CMAR 2022;Volume 14:249-55. [DOI: 10.2147/cmar.s344711] [Reference Citation Analysis]
28 Du L, Wang M, Li H, Li N, Wang F, Mei J. Identification of CCL20 and LCN2 as Efficient Serological Tools for Detection of Hepatocellular Carcinoma. Disease Markers 2022;2022:1-7. [DOI: 10.1155/2022/7758735] [Reference Citation Analysis]
29 Wei Y, Tang X, Ren Y, Yang Y, Song F, Fu J, Liu S, Yu M, Chen J, Wang S, Zhang K, Tan Y, Han Z, Wei L, Zhang B, Cheng Z, Li L, Wang H. An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity. Signal Transduct Target Ther 2021;6:421. [PMID: 34916485 DOI: 10.1038/s41392-021-00801-2] [Reference Citation Analysis]
30 Wang L, Li B, Bo X, Yi X, Xiao X, Zheng Q. Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway. Exp Mol Med 2022;54:848-60. [PMID: 35764883 DOI: 10.1038/s12276-022-00767-3] [Reference Citation Analysis]
31 Seo Y, Craig MC, Murphy ST, Feng J, Chen X, Yuneva M, Azhdarinia A. [18F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC). Molecular Imaging 2022;2022:1-8. [DOI: 10.1155/2022/5185951] [Reference Citation Analysis]
32 Jing W, Peng R, Li X, Lv S, Duan Y, Jiang S, Wang F. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/7267131] [Reference Citation Analysis]